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Abstract 
Background: Resistance development in human malaria parasites against commonly used antimalarial drugs has 
necessitated the scientific exploration of traditionally used antimalarial plants. Plant derivatives have been used for 
curing malaria historically. The present study involves in vitro evaluation of two medicinally important plants Aris-
tolochia griffithii and Thalictrum foliolosum DC used in antimalarial chemotherapy by the tribes of northeast India.
Method: Chloroform, ethyl acetate and n–butanol extracts of Aristolochia griffithii and Thalictrum foliolosum DC were 
evaluated in vitro against chloroquine sensitive (SS) and chloroquine resistance strains (RS) of P. falciparum. The tests 
were conducted following WHO standard method and the inhibition of parasite (IC50) was calculated.
Results: In A. griffithii, the IC50 value for ethyl acetate extracts against SS was 6.2 ± 0.02 μg/ml and found to be lower 
than chloroform extracts, which exhibited an IC50 value of 14.1 ± 0.1 μg/ml (t = 191.1; p < 0.0001). The IC50 values of 
both chloroform and ethyl acetate extracts for RS were higher as compared to the SS (p < 0.0001). In T. foliolosum DC 
the IC50 concentration of chloroform extracts for SS and RS were 0.5 ± 0.0 and 1.1 ± 0.0 μg/ml respectively (t = 54.2; 
p < 0.0001).
Conclusion: The present findings, although preliminary, but scientifically demonstrate that identification and isola-
tion of active compounds of these two plant materials and testing against different Plasmodium species could lead to 
the development of potential antimalarial drugs for future.
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Background
Approximately 214 million cases and 0.44 million deaths 
were reported due to malaria worldwide in 2015 [1]. 
Plasmodium falciparum, the life threatening malaria 
parasite, has developed resistance to many antimalari-
als, which has entailed the urgent need of developing new 
and effective antimalarial drugs that are affordable to the 
developing countries [2–7]. Medicinal plants have been a 
source of many antimalarial compounds such as quinine, 
artemisinin that have been used in developing potential 
antimalarial drugs. Artemisinin derivatives have been 
recommended in combination with other antimalarial 
drugs, such as amodiaquine, mefloquine, sulphadoxine–
pyrimethamine (SP) for the treatment of malaria in most 
of the endemic countries. In order to identify potential 
antimalarial compounds, several studies have been con-
ducted in malaria endemic countries to evaluate the sup-
pressive effects of various plant derivatives on malaria 
parasite [8–10].
Malaria is commonly reported in many states of India 
and neighbouring countries and the problem of reduced 
susceptibility to commonly used antimalarial drugs spe-
cifically in P. falciparum has been a growing concern for 
malaria control programme in India [11, 12]. In addi-
tion to the threat to life, malaria has been found to have 
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detrimental effect on the prosperity of the society by 
impeding the overall development, including effect on 
population growth, productivity and medical cost [13]. 
In India, the resistance to chloroquine was first detected 
in Assam, since then it prevailed into other parts of the 
country attributing countless malaria related casual-
ties. The tremendous pressure of chloroquine resistance 
has led to switch-over to artesunate-based combination 
therapy (ACT) as first line of treatment of uncomplicated 
malaria cases. Therefore, it is important that tradition-
ally used antimalarial plants are investigated to discover 
new antimalarial drugs, in order to tackle the resurging 
of antimalarial resistance in Plasmodium parasite. In the 
recent years, various studies have explored the antimalar-
ial activity of phyto-drugs based on the traditional repu-
tation of plants in malaria treatment [2, 8–10, 14, 15].
Northeast region of India has great plant biodiversity 
potential and many plants are used in traditional medi-
cine system for the treatment of various ailments [16–
19]. Among the tribes of Assam, especially Bodo, Karbi, 
Mishing and Dimasa, the plant Aristolochia griffithii is 
used against insect and snake bite, skin problem, stomach 
problems and fever. However, Adi and Monpa tribes of 
Arunachal Pradesh use Thalictrum foliolosum DC for the 
treatment of nematode worms, stomach problem, fever 
and pain. Both the plants materials are used tradition-
ally in treatment of malaria by the tribals of the region 
but experimental data to support the activity against 
malaria parasite is lacking. Therefore after collecting 
basic information about antimalarial activity of both the 
plant materials from the local tribals, we have evaluated 
the anti-plasmodial activity of A. griffithii, Hook and T. 




Aristolochia griffithii Hook, commonly called Nagbal, 
was collected from Kalamati foot Hills of Sonitpur dis-
trict of Assam, whereas Thalictrum foliolosum DC, com-
monly called Yangchira, was collected from the hills of 
Bomdila, West Kameng district of Arunachal Pradesh 
(Table  1). The aqueous extracts of root portion of both 
the plants has been used in the traditional treat of malaria 
for many years. Therefore, roots were used as testing 
material in the present study. The information about the 
use of plants in malaria treatment was gathered from 
locals through group discussions. The plants used in the 
study were identified by Dr. Ashish Kar of Tata Energy 
Research Institute, Guwahati, India and the voucher 
specimens of the plant material have been preserved in 
Defence Research Laboratory, Tezpur, India. Chloroform, 
ethyl acetate and n-butanol extracts were prepared using 
HPLC grade chemicals obtained from Merck, India Ltd., 
whereas water extracts were prepared using Millipore 
(Merck Millipore, USA) filtered water.
Preparation of extracts and maintenance of P. falciparum 
culture
Plant materials were dried under the shade and grinded 
using an electric grinder. One hundred gram of individual 
material was macerated into 1 L of each solvent and thor-
oughly mixed using a sterilized glass rod at room tem-
perature. The solution was kept for 24 h and mixed after 
every 2  h. Extracts were filtered through Whatman No. 
1 filter paper, freeze dried and kept at 4 °C in well-closed 
containers for use in the anti-plasmodial assay. The 
extracts were dissolved in dimethylsulfoxide (DMSO) at 
concentration of 1 mg/ml and then diluted with incom-
plete medium (without serum) to achieve required 
concentrations of 0.1, 0.5, 1, 5, 10, 20 and 30  μg/ml for 
evaluation against known P. falciparum chloroquine 
sensitive strain, 3D7 (SS) and chloroquine resistance 
strains, LS1 (RS). P. falciparum culture was maintained 
in  vitro on human erythrocytes (blood group O+) in 
RPMI-1640 medium (Sigma) supplemented with 10  % 
AB+ human serum, 25 mM N-2-hydroxyethylpiperazine-
N′-2-ethanesulfonic acid (HEPES buffer; Sigma Aldrich), 
25  mM NaHCO3 and 60  µg/ml gentamicin sulfate (7.2 
pH) at 37 °C and 5 % CO2 in a CO2 incubator (HERA cell 
240i, Thermo Scientific).
P. falciparum sensitivity study
Plasmodium falciparum was synchronized for the ring 
stages [20] and diluted with fresh uninfected human 
RBC’s to adjust the level of parasitaemia to 1000–8000/
µl of blood to study the sensitivity against plant extracts. 
The tests were done in 96 well microtitre plates for 
24–36  h in duplicate following standard methods [21, 
22]. An aliquot of parasite culture (100  µl) was added 
Table 1  Details of plants used in anti-malarial evaluation against P. falciparum
Name Local name Part used Collection time Location (district) GPS coordinates
Aristolochia griffithii, Hook Nagbal Root Nov–Dec 2009 Kalamati foot hills (Sonitpur) N 26°51′06″
E 92°30′12″
Thalictrum foliolosum, DC Yangchira Root Oct–Dec 2009 Bomdila (West Kameng) N 27°19′11″
E 92°26′05″
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into the each well of the plate and then 100 µl of incom-
plete culture medium containing extracts at various con-
centrations was added into the well plates. Titre plates 
were kept in CO2 incubator at 37  °C for 24–36 h. After 
24–36  h, the growth was monitored by preparing thick 
smear from each test as well as from the control well. The 
films were stained 10  % Giemsa solution (pH 7.3) and 
observed under light microscope (100×). The number of 
schizonts was counted per 200 asexual stages of parasite 
and values were compared between test wells and control 
well. The percent inhibition of parasite was calculated as 
follows:
where S = (No. of schizonts in the test well/No. of schiz-
onts in control well) × 100 [23].
The concentration at which 50  % inhibition obtained 
was recorded as IC50 value and determined using log 
dose probit method.
Data analysis
Comparison of IC50 values among sensitive and resistant 
strain and two extracts was done using paired students ‘t’ 
test, while among different extracts were made using one 
way Krusal Wallis (K) test following Dunn test of mul-
tiple comparison. All the data obtained were tested for 
normality using Kolmogorov and Smirnov (KS) method.
Results
The results of in vitro antimalarial evaluation of A. grif-
fithii have been shown in (Table 2). In SS, the IC50 con-
centration for ethyl acetate extracts was 6.2 ± 0.02 μg/ml 
and found to be statistically lower than the chloroform 
extracts, which exhibited IC50 value of 14.1 ± 0.1 μg/ml 
(t =  191.1; p < 0.0001). Similarly, for RS, the IC50 value 
for ethyl acetate extracts was lower as compared to chlo-
roform extracts, however the difference was not very 
much significant (t =  3.6; p =  0.005). Furthermore, the 
Inhibition = 100− S
IC50 values of both chloroform and ethyl acetate extracts 
for RS were higher as compared to the SS (t  =  49.6; 
p < 0.0001 for chloroform; t = 223.8; p < 0.0001 for ethyl 
acetate). Water soluble extracts and n-butanol extracts 
of A. griffithii did not show considerable activity. The 
IC50 values of water extracts for SS and RS strains were 
274.0 ± 8.2 and 390.3 ± 1.7 respectively, while the IC50 
concentration of n-butanol extracts for SS and RS were 
90.7 ± 1.1 and 139.7 ± 0.3 μg/ml respectively.
The extracts of T. foliolosum DC were also found to 
be effective against P. falciparum in the present study 
(Table  3). The IC50 concentration of T. foliolosum DC 
chloroform extracts for SS and RS were 0.5  ±  0.0 and 
1.1 ±  0.0  μg/ml respectively, which differed statistically 
(t = 54.2; p < 0.0001). For SS, the IC50 value was found 
to be lowest in chloroform extracts and higher in ethyl 
acetate extracts (K =  21.7; p  <  0.0001). The chloroform 
extracts and n-butanol extracts showed antimalarial inhi-
bition at very low concentration, however significant dif-
ferent was observed between the IC50 values of both the 
extracts for SS (t = 189.3; p < 0.0001) and RS (t = 405.1; 
p < 0.0001). The water soluble extracts exhibited an IC50 
concentration of 11.0 ± 0.1 and 10.8 ± 0.1 μg/ml for SS 
and RS respectively, indicating that the activity of water 
extracts was higher against RS as compared to the SS 
(t = 5.8; p = 0.001).
Discussion
Although many antimalarial drugs have been proved to 
be very effective against malaria parasite, but emerg-
ing resistance to these drugs have highlighted the need 
for new therapeutic agents, which could replace exist-
ing antimalarial drugs, if required. In this investigation, 
in vitro anti-plasmodial activity of two Indian medicinal 
plants, A. griffithii and T. foliolosum DC root extracts was 
studied against a well known human malaria parasite. The 
plant material extracts were found to be effective against 
SS as well as RS of P. falciparum parasite. In A. griffithii, 
the chloroform and ethyl acetate extracts showed IC50 
Table 2 In vitro IC50 values of A. griffithii extracts against P. 
falciparum
SS, P. falciparum sensitive strain; RS, P. falciparum resistant strain; IC50 values in 
μg/ml; 95 % CI, 95 % confidence interval
Extract SS (95 % CI) RS (95 % CI) t (p)
Chloroform 14.1 ± 0.1 
(14.0–14.2)
16.2 ± 0.0 
(16.2–16.3)
46.6 (<0.0001)
Ethyl acetate 6.2 ± 0.0 (6.2–6.2) 16.0 ± 0.1 
(15.9–16.2)
223.8 (<0.0001)
n-Butanol 90.7 ± 1.1 
(89.9–91.4)
139.7 ± 0.3 
(138.0–141.3)
77.2 (<0.0001)
Water 274 ± 8.2  
(248.1–299.9)
390.3 ± 1.7 
(384.8–395.7)
13.9 (<0.0001)
Table 3 In vitro IC50 values of  T. foliolosum DC extracts 
against P. falciparum
SS, P. falciparum sensitive strain; RS, P. falciparum resistant strain; IC50 values in 
μg/ml; 95 % CI, 95 % confidence interval
Extract SS (95 % CI) RS (95 % CI) t (p)
Chloroform 0.5 ± 0.0 (0.5–0.5) 1.1 ± 0.0 (1.0–1.1) 54.2 (<0.0001)
Ethyl acetate 14.9 ± 0.1 
(14.8–15.0)
26.0 ± 0.2 
(25.9–26.2)
151.4 (<0.0001)
n-Butanol 3.4 ± 0.0 (3.4–3.5) 7.3 ± 0.0 (7.3–7.4) 190.9 (<0.0001)
Water 11.0 ± 0.1 
(10.9–11.1)
10.8 ± 0.1 
(10.6–10.9)
5.8 (0.001)
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values of 14.1 ± 0.1 and 6.2 ± 0.0 for SS and 16.2 ± 0.0 
and 16.0  ±  0.10 for RS respectively. However the IC50 
values for n-butanol and water extracts were significantly 
high as compared to the chloroform and ethyl acetate 
extracts, indicating that both chloroform and ethyl ace-
tate extracts have high parasiticidal activity and were 
more effective against the malaria parasite. A. griffithii is 
a shrub climbing plant with heart shape leaves, approxi-
mately 10–28  cm long, 8–26  cm wide and distributed 
at an altitude of 2000–2900 m. This plant is perennial, 
deciduous and fragrant and has abundant distribution 
in Arunachal Pradesh and Sikkim states of northeastern 
India. Many species of Aristolochia has been used in tra-
ditional medicine for the treatment of seizures, snakebite, 
intestinal pain, gallbladder pain, arthritis, gout, rheuma-
tism, eczema, weight loss and wounds, however the anti-
malarial activity of this plant has not been evidenced by 
any scientific experimentation [24].
Further, in T. foliolosum DC, the chloroform and 
n-butanol extracts were more effective than ethyl acetate 
and water soluble extracts against both SS and RS of P. 
falciparum. The chloroform extracts of T. foliolosum DC 
were found to have highest activity against P. falcipa-
rum in present study, as the IC50 values for chloroform 
extracts against SS and RS were 0.5 ± 0.0 and 1.1 ± 0.0 
respectively. T. foliolosum DC is a perennial plant with a 
height of about 2.5 m. The plant is distributed in the tem-
perate Himalayas from 1500 to 2400 m, in the Khasi hills 
and in Kashmir, Punjab, Delhi, Uttar Pradesh, Bihar and 
Orissa. The root contains alkaloids, which has a stimulant 
action on the movements of the gastrointestinal tract, a 
depression of both the auricles and ventricles, distinct 
dilatation of the heart and induces hypotension [17]. T. 
foliolosum DC is a medicinally important plant and has 
been used as antipyretic, diuretic, febrifuge, ophthalmic, 
purgative and stomachic. It is considered to be a good 
remedy for atonic dyspepsia and is also useful in treat-
ing peptic ulcers, indigestion, toothache, hemorrhoids, 
for convalescence after acute diseases and liver disorders. 
The juice of the leaves is applied to boils and pimples 
[17]. Many studies have evaluated the antimalarial activ-
ity of plant derivatives and indicated their efficacy against 
the Plasmodium species using in vivo and in vitro meth-
ods [2, 8–10, 14, 15, 18, 19]. A recent study conducted 
in Thailand has suggested the promising activity of Plum-
bago indica Linn against both chloroquine resistant and 
chloroquine-sensitive strains of P. falciparum [25]. The 
study also indicated that the activity of plumbagin was 
relatively higher against chloroquine-resistant P. falcipa-
rum as compared to the chloroquine-sensitive P. falci-
parum, which suggests that the plants based compound 
may be more useful in clearing the resistant malaria 
parasite.
The majority of extracts used in the current study 
displayed convincing in  vitro anti-plasmodial activity 
against known chloroquine susceptibility and resistant 
strains. The aqueous extracts and decoction of both the 
plant materials are traditionally used in malaria treat-
ment in the study areas, however the organic extracts 
displayed excellent anti-plasmodial activity currently 
compared to aqueous counterparts. The present study 
using two indigenous plants has indicated that both have 
intrinsic anti-plasmodial activity. These plants have been 
used in the treatment of human malaria for many years 
by the tribes of northeastern India, however the current 
results have provided the scientific reason behind the 
folkloric use of A. griffithii and T. foliolosum DC in the 
treatment of malaria.
Conclusion
Continuous spreading of multi-drug resistant malaria 
parasite has entailed that there is a need of exploring and 
evaluating new antimalarial molecules to combat malaria. 
Current study, aimed for searching new and effective 
anti-plasmodial drugs, indicated the potential in  vitro 
antimalarial activity of A. griffithii and T. foliolosum DC 
collected from the northeastern region of India. Although 
these plants have been used in traditional medicine sys-
tem of the region, but the antimalarial activity has been 
demonstrated for the first time. The selected extracts of 
the plants were very effective against SS and RS of P. fal-
ciparum in laboratory condition, which may be exploited 
for the treatment of chloroquine sensitive as well as resist-
ance malaria patients. The present findings, however 
preliminary, but scientifically evidences the antimalarial 
potential of both the plants evaluated currently. Identifi-
cation, isolation of active compound and testing against 
different Plasmodium species could lead to the develop-
ment of more effective antimalarials for the future.
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